Is good cholesterol always good?

BMJ

Volumn 329, Issue 7464, 2004, Pages 471-472

  Thompson, Gilbert R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TORCETRAPIB; UNCLASSIFIED DRUG;

ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; DNA POLYMORPHISM; EDITORIAL; GENE MUTATION; GENETIC VARIABILITY; HEALTH PROGRAM; HEART PROTECTION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LONGEVITY; PRIORITY JOURNAL; RATING SCALE;

CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; CORONARY DISEASE; GLYCOPROTEINS; HUMANS; LONGEVITY; POLYMORPHISM, GENETIC;

EID: 4344698327     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.329.7464.471     Document Type: Editorial

References (12)

1. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousidan S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA 1986; 256: 2835–8.
2. Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, et al. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med 2004; 350: 1505–15.
3. Knoblauch H, Bauerfeind A, Toliat MR, Becker C, Luganskaja T, Gunther UP, et al. Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Hum Mol Genet 2004; 13: 993–1004.
4. Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesterol ester transfer protein by alcohol. J Lipid Res 1992; 33: 737–44.
5. Ellison RC, Zhang Y, Qureshi MM, Knox S, Arnett DK, Province M. Investigators of the NHLBI Family Heart Study. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute family heart study. Am Heart J 2004; 147: 529–35.
6. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Lipton R, et al. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003; 290: 2030–40.
7. Hirano K, Yamashita S, Nakajima N, Arai T, Maruyama T, Yoshida Y, et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol 1997; 17: 1053–9.
8. Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, Tall AR. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97: 2917–23.
9. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation 2000; 101: 1907–12.
10. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez Lahoz C, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 2000; 20: 1323–9.
11. Brousseau ME, O'Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency. Veterans Affairs HDL cholesterol intervention trial. Arterioscler Thromb Vasc Biol 2002; 22: 1148–54.
12. Thompson GR, Partridge J. Coronary calcification score: the coronary-risk impact factor. Lancet 2004; 363: 557–9.